Drug Evaluation Committee Report on Clinical Trial Network Activation Activities
Clinical Evaluation Subcommittee
May 2015
In the 2013-2014 Clinical Evaluation Subcommittee Special Project-1, we provided consultation and advice to activate clinical trial NWs selected through an open call to become good clinical trial NWs that implement ideal functions and roles for companies.
The activity process of this project and the activities (Best Practice) that were considered to fall under "specific functions and roles to become a good Clinical Trial NW" are described in the main body of the report, and specific activities for improvement of individual Clinical Trial NWs are summarized in a separate volume.
We hope that this report will help individual NWs to promote activation activities and lead to the utilization of clinical trial NWs and the revitalization of clinical trials in Japan.
- Report on Activities to Activate Clinical Trial Networks (1MB)
- Report on Activities to Activate Clinical Trial Networks -Akita Clinical Trial Network- (7MB)
- Report on the Activities to Activate Clinical Trial Network -Toto-Umi Clinical Trial Network- (1MB)
- Report on the Activities to Activate Clinical Trial Networks -Ibaraki Clinical Trial Network- (1MB)
Deliverables of the Drug Evaluation Committee Return to list of all deliverables